TAP To Discuss Gout Treatment With FDA Following Second “Approvable” Letter

Febuxostat would be the first new treatment for chronic gout in more than 40 years.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet